Connect to some of the region’s most innovative HealthTech startups. Experience what many of the technologies can do to help you or those you care for lead richer, longer and healthier lives. Join us in what will be the leading HealthTech event in Asia.
2016 HIGHLIGHTSLast years' event attracted 350 delegates from Industry, Professional Services, Academia, VC/PE & the Start-Up world
Judith J. LiPartner, Lilly Asia Ventures
Judith J. Li, is a Partner at Lilly Asia Ventures (LAV), based in Hong Kong / Shanghai and focused on early and growth stage investments across biopharmaceuticals, medical devices, and diagnostics both domestically and cross-border. Judith holds board appointments at a variety of LAV’s portfolio companies including Nextcure, Crown Biosciences, Just Biotherapeutics, and Veritas Genetics. Her prior experience includes McKinsey’s New York office, hospital administration at Partners Healthcare, and co-founding an interventional nephrology medical device venture. Judith holds a B.A. in Neurobiology from Harvard and M.B.A. from Harvard Business School, and currently resides in Hong Kong with her husband Ben, splitting her time between Hong Kong, Shanghai, and the Bay Area.
Benjamin Joffe is a Partner at HAX, recognized as the world's most active accelerator and seed investor in hardware startups, with over 180 IoT, robotics and health tech portfolio companies. Notable companies include "lego for robotics" Makeblock, NextThing (makers of the world's first $9 computer) and Simbe Robotics. The B2C startups of HAX ran over 70 successful crowdfunding campaigns with an average funding above $400,000, including 8 in the world’s Top 100. Benjamin has lived in China, Japan and South Korea since 2000 where he worked in strategy, telecom, Internet and gaming before turning to hardware in 2013. Born in Paris, Benjamin speaks English, French, Japanese and a fair bit of Mandarin. Benjamin is also an angel investor and a frequent speaker in global tech conferences including TEDx, TechCrunch Disrupt, Slush and Pioneers, his research shared online has been seen by over 1 million readers. He is a contributor for Forbes, TechCrunch and was a columnist for China Entrepreneur Magazine. Benjamin is also frequently quoted in numerous media such as WIRED, Bloomberg and The Economist. When he's not working with startups or on planes, Benjamin enjoys yoga, hiking, BJJ and reading non-fiction.
Tim NgCTO, Now Healthcare Group
Chief Technology Officer at Now Healthcare Group - creating new technology solutions and innovations for the mHealth sector. Focus on commercial technology strategy, DevOps and next gen architecture. Tim has over 16 years’ experience leading tech teams in a variety of settings. Some of the core platforms developed by Tim have been integrated with large scale Enterprise Systems and Web APIs with Yahoo, Google and MIVA. Prior to joining Now Healthcare Group, Tim has worked for Fujitsu, Latitude Group, threeSixty Services LLP (Standard Life) and tech start-up Property Moose.
Dr NT CheungHead of Information Technology & Health Informatics / Chief Medical Informatics Officer, Hospital Authority
NT Cheung is the Head of Information Technology & Health Informatics and Chief Medical Informatics Officer of the Hong Kong Hospital Authority (HKHA) and also the Consultant for eHealth for the Hong Kong Government. He has taken HA from a virtual “green fields” site to today’s situation where clinical information systems have become ubiquitous and indispensable in the care delivery process. His current work focuses on taking the Hospital Authority’s Clinical Management System (CMS) on a generational leap to the next level of computerized record system functionality to improve the already world-class facilities in the CMS for the documentation and effective management of disease.
Connect to some of the region’s most innovative HealthTech startups.
Alex Cahana, MD, MAS, FIPPSVP Digital Strategies, TRT International US
With over 25 years of clinical experience Dr. Cahana is Senior VP at TRT International and the newly formed TRT International US Ltd. He works with State and Federal agencies on policies to improve health care and reduce opioid-related deaths, is a Subject Matter Expert for the Department of Defense and the Veterans Administration and consults multiple companies and start ups on how to integrate digital technologies and digiceuticals into healthcare. He is a Professor in Science, Technology and Health Studies at the University of Washington and teaches Healthcare Redesign at the Pratt Institute of Design in NYC. Dr. Cahana has published over one hundred publications and received multiple awards, among them -- the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) Best Practice, the Association of American Medical Colleges Innovation Health Care award, and the University of Washington President’s medal for remarkable leadership, social impact and public service.
Lee DentithFounder & CEO, Now Healthcare Group
Lee Dentith is the Founder & CEO of Now Healthcare Group. Passionate about new ideas, technology & cutting-edge innovation, Lee has strategically directed several successful UK projects for businesses across multiple sectors. He established the largest independent media agency outside of London, developing unique software for analysing traditional and digital media spend and working with clients in the healthcare sector such as the NHS, Bupa Partnership and Spire. Lee was involved in Google’s arrival into the UK market, working closely with the technology company’s Irish branch in an advisory role which saw him contribute to the coordination of Google’s B2B strategies.
Albert is the founder of AcesoBee, the creator of acesome, a mobile Personal Care Plan (PCP) and Point of Care (POC) System. A self-made entrepreneur in the eHealth and HealthTech industry, Albert started out as a Healthcare Solutions Specialist at IBM. In 2001, his first business venture Healthbasic.com, healthcare portal and clinic solutions software provider was acquired by Quality Healthcare. Albert holds a bachelor degree in Computer Science and an MBA degree from the Hong Kong University of Science and Technology.
Sloan is an American engineer from MIT with deep ties to the Silicon Valley startup community - a serial entrepreneur and inventor who has built startups in four countries and raised millions of USD in seed funding for Lifespans and previous ventures. He was the former Chief Design Officer of One Earth Designs, and has work experience at several multinational medical device firms, including Stryker and CR Bard. Sloan received a BSc from MIT and an MFA from the Rhode Island School of Design, both in industrial design, and is a final-year medical engineering PhD candidate in the HKU Faculty of Medicine.
Guangfei JiCEO & Chairman, TRT International
20 years of overseas investment experience and global resource integration capacity, medical and health, Chinese medicine, energy industry experience, and Tong Ren Tang co-founder of “TRT International”
Kelvin Chiu (MPhil, MBA)CEO, Sanwa Biotech
Kelvin has extensive experience in advanced biotechnology & operational strategy. He has been involved in multiple international M&A projects and global integrations including the US$700 million acquisition of Next-Gen sequencer company Ion Torrent. He holds a M. Phil. Degree in Molecular Biology from the University of Hong Kong and a MBA degree from Anderson School of Business UCLA with focus in Operational Strategy & Advanced International Management (AIM).This background has given him extensive experience in pre-clinical project management and transition from prototype commercialization through product launch. Kelvin has in-depth knowledge of business models and cultures in APAC.
Epidemiologist, HealthTech consultant, data geek, globetrotter. Co-founder and Director of Science of Gather Health, an mHealth startup aimed at improving chronic disease care in Asia. Experience with private companies, governments, and international NGOs in Africa, Asia, and North America. Currently consulting on healthcare projects.
Jun XuVP, Ally Bridge Group
Mr. Xu has years of experience in due diligence, corporate finance and strategic management across the Asia Pacific region. Prior to joining ABG, Mr. Xu was an investment banker at Barclays Capital, CICC and Houlihan Lokey, working on IPO, M&A and take-private transactions in technology and healthcare sectors across Asia Pacific. Mr. Xu began his career as a management consultant at Booz Allen Hamilton, where he advised global companies and leading PE firms on the development of China business strategy, corporate transformation, portfolio management and M&As. Mr. Xu holds an MBA from the Wharton School of University of Pennsylvania and a BA from Fudan University in China.
Steve MonghanChief Investment & Innovation Officer, Gen.Life & Ltd Partner @ True Global Ventures
Steve Monaghan is Regional Director, Head of Edge AIA accountable for AIA’s group innovation agenda, a Limited Partner and investment committee member in True Global Ventures, Vice Chairman of Borderless Healthcare Mobile China, a board member of Proximiti and a private investor in Artificial Intelligence, Life Sciences, HealthTech and Fintech. Originally a commercial pilot, Steve has held a number of senior corporate and banking roles in product, marketing, operations and general management. He has worked for leading corporations and financial institutions including Dell, Compaq, Citigroup, OCBC, Shinsei and DBS Bank. Throughout his career, Steve has specialized in introducing new business models, businesses and products in all major markets in Asia and has filed 6 patents in FinTech. At AIA Steve and the Edge team have built Asia and Oceania's leading corporate Accelerator ranked No. 5 overall, become the first Insurance company to join R3 guiding the future of insurance on the blockchain, pioneered Digital Health in Asia and is pioneering new applications of AI in Insurance in partnership with Universities and Government research institutions.
Danny Yeung, a serial entrepreneur, serves as Chief Executive Officer for Prenetics, a technology-driven life sciences company specializing in digital health programs utilizing genetic testing. Prior to Prenetics, Danny was Founding Partner at SXE Ventures having led multiple investments in genetic testing companies. Danny had also founded uBuyiBuy in 2010 which was acquired by Groupon, and served as CEO of Groupon East Asia.
Prof. Ronald Li co-founded Novoheart with Professors Kevin Costa (Mount Sinai) and Michelle Khine (UC Irvine), with the vision of revolutionizing drug discovery and development of heart therapeutics with proprietary bioengineered human heart constructs, and the development of these tissues into cell-based regenerative heart therapies with superior safety and efficacy. Prof. Li is also currently Executive Director of Ming-Wai Lau Centre for Reparative Medicine, Karolinksa Institutet (KI), Sweden, with a concurrent professorial cross appointment at the Dr. Li Dak-Sum Research Center, University of Hong Kong (HKU)-KI Collaboration in Regenerative Medicine of HKU.
Tony YungCEO, Sanomics
Mr. Yung serves as the CEO of Sanomics Limited, which is one of the leaders in cancer genomics services in Hong Kong and the Asia Pacific region. The Sanomics team is dedicated to bringing the latest and best genomics technologies to the local healthcare sectors, and helping oncologists manage patients with high-quality services
Dr. Corinna Ockenfeld received her Ph.D from the Hong Kong Polytechnic University and is specialized in Rehabilitation Robotics. She has more than 10 years’ experience in patent application, end-to-end prototyping, product development, and quality control in the healthcare sector. She currently works at NISI (Hk) Limited as Clinical Affairs and IP Manager.
Cadmon Lim is a biomedical scientist and entrepreneur focus on application of gene technology to disease management. He has over 20 years’ experience in medical laboratory science and biomedical research including working in local hospitals, university and private sectors. GemVCare is his second startup.
Living, working and investing in Asia since 1999. Building global ecosystems to transform healthcare, education and work through direct venture capital investment, corporate innovation partnerships, and supporting social impact / non-profit organizations.
Mr. Andrew Young Meng-cheung joined Hong Kong Science and Technology Parks Corporation (HKSTP) in September 2011. As the Chief Commercial Officer, he is responsible for formulating and executing strategies and policies to engage with technology companies and institutions to enrich the ecosystem for technological innovation. He is also responsible for drawing up strategies for strategic partnerships with industry associations, universities and research institutes both locally and internationally to facilitate technology transfer and commercialisation. Mr Young is in charge of the Incubation Programmes and Corporate Venture Fund to nurture Tech-Entrepreneurs. Mr. Young brings more than 20 years of experience in senior management positions in the high technology industry. He has Bachelor of Engineering Degree in Mechanical Engineering from the South Australian Institute of Technology and a Master of Business Administration Degree from the University of South Australia.
Jonthan KriveCEO & Co-Founder, Civet BioSciences
Civet BioSciences, is a multi-faceted microbiome therapeutics company in Hong Kong. Jonathan started the company with two business partners after a close friend’s incurable digestive illness lead the team to begin looking into microbiome-focused therapeutics. Previously Jonathan was a corporate development director for a US tech company and an investment manager for a Chinese healthcare conglomerate, focusing on hospital and pharmaceutical investment projects.
Lillian PoonPrincipal, BCG
Ms. Poon is a core member of the BCG Greater China Healthcare team and has broad project experience in growth, commercial strategy, and organization transformation across U.S. & China markets. She is also a co-author of the BCG Perspective article "China's Digital Healthcare Revolution". Ms. Poon holds an MBA from Wharton and a BSc from the University of Pennsylvania.
Charles NgAssoc. Director-General of Investment Promotion, InvestHK
Charles heads up one of two sector-focused divisions that is responsible for helping overseas and Mainland companies to establish or expand their business presence in Hong Kong. His teams are responsible for Financial Services, Financial Technology, Innovation and Technology, Information and Communications Technology, Startups and Research & Knowledge Management. Mr Ng leads the StartmeupHK programme which aims to promote Hong Kong as a premier startup destination in Asia, attract overseas entrepreneurs to the city and help to build it into a leading destination and hub for innovation and entrepreneurship.
Karin is the Managing Director of APAC BioHealth Consulting a boutique advisory firm focusing on the healthcare industry in Asia. We help clients with cross-border innovation, commercialization & investment exchanges. Karin has 20 years work experience in the healthcare industry. She started her career in the UK and has spent the last 15 years based in Asia where she has held various senior management positions for MNC’s such as Fresenius Medical Care, Medtronic and Baxter. She has an MBA from London Business School, a Ph.D. in Genetic Engineering (King’s College, London) & recently completed the Financial Times Non Executive Director’s diploma. Karin is also the Co-Vice Chair of the Healthcare Committee of the British Chamber of Commerce. Karin has a Ph.D in Genetic Engineering & a MBA from London Business School.
OPENING REMARKSPatrick Nip Tak Kuen, Permanent Secretary for Food & Health
1// LEE DENTITH (CEO) & TIM NG (CIO): Now Healthcare Group (UK)
“How telemedicine and medicine distribution platforms are disrupting the delivery of healthcare”
2// DR. ALEX CAHANA (+GUANGFEI JI): SVP Digital Strategies, TRT International (USA)
“Virtual Reality as a ‘Digiceutical’: A new Vision for Digital Integrative Care” > keynote profiles
TECHNOLOGY ENABLERS & THEIR APPLICATION TO HEALTHTECH INNOVATION//////
Danny Yeung (Prenetics): Genomics
Benjamin Joff (HAX): Hardware in HealthTech
Dr. Corinna Ockenfeld (NISI): Robotics
Steve Monaghan (Gen.Life): AI
Jonathan Krive (Civet Bio): Microbiome
HEALTHTECH START-UP PITCHES//////
Lifespans: Implants for osteoporosis
NovoHeart: Bioartificial human heart
Gather Heath: App for controlling diabetes
Sealantis: Algae-based tissue adhesives
Gemvcare: Data analytics for diabetes
Acesobee: E-healthcare record platform
Sanwa Biotech: Lab-on-chip diagnostics
Sanomics: Cancer Genomics
INVESTING TRENDS IN HEALTHTECH
Judith Li: Partner at Lilly Asia Ventures
Benjamin Joffe: HAX
Tytus Michalski: Fresco Ventures
Jun Xu: Ally Bridge Group
Lillian Poon (BCG): Moderator
IT INNOVATION IN HONG KONG HOSPITAL AUTHORITY
Dr. NT Cheung: HK Hospital Authority
HOW DO ACCELERATORS / INCUBATORS ADD VALUE TO START-UPS?
Benjamin Joffe: HAX
Steve Monghan: Gen.Life
Andrew Young: HK Science & Technology Park
Bob Crozier: AIA
Karin Munasinghe: Moderator
TICKETSWe have two class of tickets available for purchase through Eventbrite.
Start-Ups ticket (discount) HK$550
General admission ticket HK$950
FAQ & QUESTIONSGet the answer to common questions here or send your questions in the contact form.
VENUE INFO— PMQ
35 Aberdeen Street
Central, Hong Kong
— 20 January 2017
— Time: 9:00 AM to 7:00 PM
— APAC BioHealth Consulting
— +852 9040 1120
NEWSLETTERGet news about HealthTech Asia in your inbox!
BROUGHT TO YOU BY
Interested in becoming a sponsor? Get in touch